In this presentation Richard Manch, MD, discusses management of patients with ascites. He discusses the indications and contraindications for paracentesis, initial laboratory investigation of ascitic fluid, the core elements for… […]
Keyword: hcv
National Clinician Consultation Center | December 6, 2023
In this presentation, Chris Bositis, MD, AAHIVS, provides an overview, via the game “Jeopardy”, of the National Clinician Consultation Center, services available through the national HIV, PEP, PrEP, HCV, and… […]
Read More… from National Clinician Consultation Center | December 6, 2023
Updates in CDC HCV Testing Recommendations | November 15, 2023
In this presentation, Dr. Paulina Deming describes the risk of HCV infection in perinatally exposed children and identifies when children with perinatal exposure should be tested for HCV. […]
Read More… from Updates in CDC HCV Testing Recommendations | November 15, 2023
Common HCV DAA Drug Interactions | September 27, 2023
In this presentation, Dr. Paulina Deming describes the interaction potential between DAA therapies and common medications, and identifies when DAA therapies and diabetic medications are most likely to result in… […]
Read More… from Common HCV DAA Drug Interactions | September 27, 2023
Recognizing Cirrhosis | September 6, 2023
In this presentation, Dr. Karla Thornton discusses the natural history of chronic liver disease, how to recognize cirrhosis and steps to take after determining someone has cirrhosis. […]
Ending the Syndemic – An Introduction | August 24, 2023
In this presentation, Dr. Jorge Mera, Indian Country ECHO Medical Director and Director of Infectious Diseases at Cherokee Nation, introduces the rationale, program design, leadership policies, and tools that may successfully… […]
Read More… from Ending the Syndemic – An Introduction | August 24, 2023
HCV Treatment Monitoring: Keeping it Simple | August 23, 2023
In this session, Dr. Paulina Deming discusses baseline laboratories recommended for HCV treatment evaluation, identifies patients eligible for simplified monitoring and shares HCV treatment monitoring recommendations. […]
Read More… from HCV Treatment Monitoring: Keeping it Simple | August 23, 2023
Evaluation of Infectious Diseases in People With Substance Use Disorders: An Opportunity for Disease Elimination | August 16, 2023
In this presentation Jorge Mera, MD, discusses evaluation of infectious diseases for people with substance use disorders. He discusses the syndemic of HIV, HCV, STIs and SUDs, the intersection between… […]
Starting an Effective Model to End the Syndemic at Cass Lake | December 6, 2023
In this presentation, Whitney Dickson, PharmD, shares the story of Cass Lake’s program to end the syndemic using a comprehensive approach to prevent, screen, treat, and manage HCV, HIV, SUDs,… […]
Read More… from Starting an Effective Model to End the Syndemic at Cass Lake | December 6, 2023
HCV Management and Treatment Guidelines | December 5, 2023
In this training, Dr. Jorge Mera discusses treatment and management of patients with hepatitis C in primary care, including medications, approaches to treatment, medication interactions, and treatment monitoring. […]
Read More… from HCV Management and Treatment Guidelines | December 5, 2023